At a glance
ClinicalIndex Comparison RecordN/ACompleted· 612 enrolled
Drug / intervention
Dynamic Contrast-Enhanced Ultrasound Imagingprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Contrast-Enhanced Ultrasound Evaluation of Focal Liver Lesions in Patients With Cirrhosis or Other Risk Factors for Developing HCC
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University·interventional·Posted Oct 23, 2017·Updated May 18, 2025
In Brief
A clinical study evaluating Dynamic Contrast-Enhanced Ultrasound Imaging for Liver Cirrhosis. Completed, enrolled 612 participants across 11 sites in 6 countries.
Detailed Summary
This clinical trial studies how well contrast-enhanced ultrasound imaging works in diagnosing liver cancer in patients with cirrhosis. Diagnostic procedures, such as contrast-enhanced ultrasound imaging, may help find and diagnose liver cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cirrhosis
CountriesCanada, France, Italy, Switzerland, United Kingdom, United States
CollaboratorsNational Cancer Institute (NCI), GE Healthcare, Bracco Diagnostics, Inc
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 2017
Enrollment StartJan 2018
Primary CompletionAug 2021
Study CompletionNov 2022
TodayJul 2026
First PostedOct 23, 2017
Enrollment StartJan 19, 2018
Primary CompletionAug 31, 2021
Study CompletionNov 3, 2022
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 8.7 years ago
Interventions
Dynamic Contrast-Enhanced Ultrasound Imagingprocedure
Undergo CEUS